Dexus enters JV to set up healthcare fund



Dexus has entered into a joint venture agreement (JV) with Commercial & General (C&G) to establish a new wholesale unlisted healthcare fund.
Under the terms of the deal, Dexus and C&G would co-invest in the fund and would set up a jointly owned investment manager, with Dexus’ initial co-investment of approximately $80 million.
The responsible entity (RE) of the new Australian Healthcare Property Fund would be wholly owned by Dexus as part of the group’s funds management platform.
Also, the new fund would be seeded with $370 million worth of properties, including the Adelaide Calvary Hospital and GP Plus Healthcare Centre in Adelaide.
Dexus said that healthcare property presented an opportunity for the company to drive long-term returns through leveraging capabilities of its platform across transactions, development, leasing and investment management.
Dexus’ chief executive, Darren Steinberg, said: “We are pleased to partner with C&G and look forward to continuing to build scale in the growing healthcare sector which will benefit from the underlying mega-trends of population growth and an ageing demographic”.
“We see this property asset class as a logical extension to our funds management platform.”
Marketing of the new fund would start in July with a view to launching the fund by the end of 2017, the company said.
Recommended for you
BlackRock has announced its plan to acquire real estate investment firm ElmTree Funds which will be integrated into its new private financing solutions business.
With share price growth of 45 per cent for FY25, Australian Ethical has shared why it believes the firm has done so well compared to its active peers.
ETF investors would be wise to consider global or European exposure for their equity ETF allocations, according to AXA IM, with US government action expected to hit both its equity and bond performance.
A specialist ETF provider is seeking to become “the new Betashares” with its active ETFs, thanks to its use of algorithms to achieve outperformance.